a16z Capital Management, L.L.C.

Position in RVMD — Revolution Medicines, Inc.

CIK 1540358 MENLO PARK, CA

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$89,576,877

+$16,211,342 QoQ

Shares Held

921,099

0.0% QoQ

Ownership

0.433%

of shares outstanding

% of Portfolio

6.94%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

a16z Capital Management, L.L.C. holds $304,679,821 across 8 Biotechnology names. RVMD ranks #1 (29.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc. This page	921,099	$89,576,877
2	NAUT	Nautilus Biotechnology, Inc.	17,653,917	$68,497,197
3	MAZE	Maze Therapeutics, Inc.	1,702,225	$50,811,416
4	ERAS	Erasca, Inc.	2,862,500	$46,315,250
5	DMRA	Damora Therapeutics, Inc.	1,236,157	$32,016,466
6	CAMP	Camp4 Therapeutics Corp	2,125,339	$9,372,744
7	AKTS	Aktis Oncology, Inc.	415,000	$7,424,350
8	DNA	Ginkgo Bioworks Holdings, Inc.	108,568	$665,521

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$89,576,877	921,099	0.0%	Shares	Sole	2026-05-15
2025-12-31	$73,365,535	921,099	-66.5%	Shares	Sole	2026-02-17
2025-09-30	$128,356,024	2,748,523	0.0%	Shares	Sole	2025-11-14
2025-06-30	$101,118,161	2,748,523	0.0%	Shares	Sole	2025-08-14
2025-03-31	$97,187,773	2,748,523	0.0%	Shares	Sole	2025-05-15
2024-12-31	$120,220,396	2,748,523	0.0%	Shares	Sole	2025-02-12
2024-09-30	$124,645,518	2,748,523	0.0%	Shares	Sole	2024-11-13
2024-06-30	$106,670,177	2,748,523	0.0%	Shares	Sole	2024-08-13
2024-03-31	$88,584,896	2,748,523	-51.8%	Shares	Sole	2024-05-15
2023-12-31	$163,391,881	5,697,067	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.